Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Receptos Completes Enrollment of RADIANCE Phase 3 Trial of Ozanimod in Relapsing Multiple Sclerosis
Neuroprotective effect of masitinib in rats with postischemic stroke.
A high-density screen for linkage in multiple sclerosis.
4-aminopyridine toxicity: a case report and review of the literature.
Testing for urinary tract colonisation before high-dose corticosteroid treatment in acute multiple sclerosis relapses: prospective algorithm validation.
Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome.
Long-Term Safety and Efficacy Study of BIIB017 (PEGylated Interferon Beta-1a) (ATTAIN)
Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics.
Fatigue, depression and sleep disturbances in Iranian patients with multiple sclerosis.
Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions.
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis.
Extoxnet (extension toxicology network), 4-aminopyridine
Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome.
Race to Erase MS Forum and Expo
Balance impairment in people with multiple sclerosis: Preliminary evidence for the Balance Evaluation Systems Test.
Fingolimod is a potential novel therapy for multiple sclerosis.
Saccadic intrusions: review and update.
Chemistry, toxicology, pharmacology and pharmacokinetics of idebenone: a review.
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility.
Vitamin D intake and incidence of multiple sclerosis.
Analysis: Healthy babies born after accelerated elimination of teriflunomide
Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration.
Self-reactive CD4(+) T cells activated during viral-induced demyelination do not prevent clinical recovery.
Treatment with 4-aminopyridine improves upper limb tremor of a patient with multiple sclerosis: a video case report.

Pages